Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BHCUX vs. PRHSX: which is better?

Bottom line

BHCUX vs PRHSX: the short answer

BHCUX (Baron Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.

But PRHSX is far broader, holding 279 positions to 43 for BHCUX, so beyond the top names it adds exposure BHCUX doesn't have.

PRHSX is cheaper at 0.83% vs 0.85% — a difference of $2.00 a year per $10,000 invested.

Over five years, PRHSX returned +4.2% a year vs +2.8% for BHCUX.

Updated Nov 19, 2026

BHCUX vs PRHSX side by side

BHCUXPRHSX
TypeMutual fundMutual fund
Fund familyBaron SelectT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.85%0.83%
Annual cost per $10k$85$83
10-yr cost on $10k (prospectus)$1,049$1,025
Max front load——
12b-1 fee0%—
1-yr return+10.3%+17.7%
5-yr return (annualized)+2.8%+4.2%
10-yr return (annualized)—+9.1%
Best quarter—+23.5%
Worst quarter—−15.8%
Net assets (fund)$114.1M$11.9B
Number of holdings43279
Portfolio turnover74%62%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

13 of BHCUX's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingBHCUXPRHSX
Eli Lilly & Co13.66%14.28%
Johnson & Johnson5.56%6.63%
Thermo Fisher Scientific Inc3.91%2.52%
UnitedHealth Group Inc3.28%5.99%
Vertex Pharmaceuticals Inc2.61%2.28%
Merck & Co Inc2.48%4.01%
Guardant Health Inc2.17%1.23%
Kymera Therapeutics Inc2.01%0.89%
Gilead Sciences Inc1.99%2.82%
Natera Inc1.93%1.44%
Intuitive Surgical Inc1.74%1.87%
Protagonist Therapeutics Inc1.72%0.85%
Elevance Health Inc1.69%1.53%

Source: SEC Form N-PORT

BHCUX top 10

  1. Eli Lilly & Co — 13.66%
  2. Mettler-Toledo International Inc — 5.60%
  3. Johnson & Johnson — 5.56%
  4. Argenx SE — 4.23%
  5. Thermo Fisher Scientific Inc — 3.91%
  6. Roivant Sciences Ltd — 3.88%
  7. Teva Pharmaceutical Industries Ltd — 3.86%
  8. Welltower Inc — 3.38%
  9. UnitedHealth Group Inc — 3.28%
  10. RadNet Inc — 3.24%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between BHCUX and PRHSX?
BHCUX (Baron Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds. But PRHSX is far broader, holding 279 positions to 43 for BHCUX, so beyond the top names it adds exposure BHCUX doesn't have.
Which is cheaper, BHCUX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both BHCUX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.